1. Home
  2. FIEE vs CRVO Comparison

FIEE vs CRVO Comparison

Compare FIEE & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FiEE Inc

FIEE

FiEE Inc

HOLD

Current Price

$3.65

Market Cap

36.7M

Sector

Utilities

ML Signal

HOLD

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$2.78

Market Cap

39.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIEE
CRVO
Founded
1977
2001
Country
Hong Kong
United States
Employees
3
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.7M
39.3M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
FIEE
CRVO
Price
$3.65
$2.78
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$23.00
AVG Volume (30 Days)
2.2K
15.7M
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,006,510.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$2.13
52 Week High
$7.95
$13.13

Technical Indicators

Market Signals
Indicator
FIEE
CRVO
Relative Strength Index (RSI) 39.79 40.64
Support Level $2.43 $2.13
Resistance Level $4.14 $4.03
Average True Range (ATR) 0.25 0.32
MACD 0.01 -0.07
Stochastic Oscillator 28.30 3.68

Price Performance

Historical Comparison
FIEE
CRVO

About FIEE FiEE Inc

FiEE Inc is a digital service provider focused on integrating artificial intelligence (AI) and data analytics into content creation, digital authentication, and brand management. Its business model leverages a cloud-based SaaS platform designed to support clients in developing, managing, and optimizing their digital presence across platforms, including customized graphics and posts, short videos, and editorial calendars aligned with brand goals. Additionally, it offers comprehensive software development and maintenance services, delivering custom software solutions from system design and development to deployment and post-launch maintenance. It services consist of three core areas: digital content and MCN services, software development services, and digital authentication services.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: